Wegovy must only be taken under medical supervision.
Likewise, the authors of this study call for more research into the efficacy (and safety) of GLP-1 analogs in IBD for its anti-inflammatory properties
There may be some changes in manufacturing, packaging, components, or external appearance from the producing companies
These findings suggest that treating obesity requires long-term commitment, not just from patients but from healthcare systems too.' Source: University of Oxford 19.01.2026
In major trials, semaglutide produced about 15% weight loss around 68 weeks, and tirzepatide produced greater weight loss at around 72 weeks in head-to-head comparison
As AUD is a heterogeneous disorder with a multifaceted pathophysiology, the possibility that combinations of GLP-1 and other gutbrain axis peptides synergistically reduce alcohol drinking should be explored in future studies